Bacterial Protein Expression

Bacterial Protein Expression

Manufacturing

Information

Choosing bacterial expression systems for the production of recombinant proteins, offers several advantages: A shorter timeline for the entire process from cloning to protein recovery, inexpensive production processes, high protein yields and a high flexibility in scale. While this expression system is not suitable for every project, smaller peptides and recombinant proteins without posttranslational modifications can easily be expressed in E. coli. InVivo`s protein experts are happy to help you choose the right expression system for your application. For protein expression in E. coli, we offer a huge selection of different culture vessels (2 L shaker flasks to 50 L bioreactors) to ensure that we can meet all your needs. Furthermore, 10 L bioreactors (OD 30-80) are available for high cell density cultivation. Our services include: cDNA synthesis and cloning into protein expression vector (including codon optimization and attachment of tag (e.g. HIS-tag) for subsequent protein purification) Small scale pilot production to assess the feasibility of expression and purification of your protein of interest (Feasibility Study) Large scale production after successful test production
InVivo BioTech Services GmbHInVivo is an ISO-certified German contract manufacturing organization (CMO) with more than 20 years of experience in cell culture and the development and production of monoclonal antibodies and recombinant proteins  for research, diagnostic and pre-clinical use. As an independent service provider, InVivo offers cost-effective outsourcing solutions plus a wide range of different expression systems to meet customer needs. We work with companies worldwide, including major diagnostic companies, research institutes and biopharmaceutical companies. We provide a complete range of antibody services, from antibody optimization and development to protein labelling. For monoclonal antibody production, our capacity ranges from  the milligram to the kilogram scale, and we have experience in the expression of antibodies from all kinds of subclasses and species. Besides mAB production, InVivo also focuses on the expression of recombinant proteins, including difficult-to-express proteins. Therefore we established a proprietary, highly-optimized expression system for transient gene expression in HEK cells, called InVest. This system combines an optimized host cell line, sophisticated vector design, large-scale plasmid preparation, serum-free cultivation media and a novel transfection reagent. InVivo now offers diverse SARS-CoV-2 Antigens in large-scale quantities, which are suitable for the development of highly sensitive IVD kits. Please visit our website for more information: https://www.invivo.de/cell-line-development/sars-cov-2-antigens/ For more details on our complete service portfolio please visit www.invivo.de

Log in

See all the content and easy-to-use features by logging in or registering!